Literature DB >> 3289992

Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs.

W K Ward1, B J Wallum, J C Beard, G J Taborsky, D Porte.   

Abstract

To determine which test of islet function is the most sensitive indicator of subclinical beta-cell loss, we studied six conscious dogs before and 1 and 6 wk after removal of the splenic and uncinate lobes [64 +/- 2% pancreatectomy (PX)]. To assess hyperglycemic potentiation, acute insulin secretory responses (AIR) to 5 g i.v. arginine were measured at the fasting plasma glucose (FPG) level after PG was clamped at approximately 250 mg/dl and after PG was clamped at a maximally potentiating level of 550-650 mg/dl. FPG levels were unaffected by PX (112 +/- 4 mg/dl pre-PX vs. 115 +/- 5 mg/dl 6 wk after PX, P NS). Similarly, basal insulin levels remained constant after PX (11 +/- 2 microU/ml pre-PX vs. 11 +/- 1 microU/ml 6 wk after PX, P NS). The AIR to 300 mg/kg i.v. glucose decreased slightly from 42 +/- 9 microU/ml pre-PX to 32 +/- 5 microU/ml 6 wk after PX (P NS), and thus the beta-cell loss was underestimated. In contrast, insulin responses to arginine declined markedly after PX. The AIR to arginine obtained at FPG levels declined from 23 +/- 3 microU/ml pre-PX to 13 +/- 2 microU/ml 6 wk after PX (P = .04). The AIR to arginine obtained at PG levels of approximately 250 mg/dl declined even more, from a pre-PX value of 56 +/- 7 microU/ml to 21 +/- 4 microU/ml 6 wk after PX (P = .02).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289992     DOI: 10.2337/diab.37.6.723

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

1.  Insights Into the Progression of β-Cell Dysfunction Caused by Preterm Birth.

Authors:  Sean W Limesand
Journal:  Endocrinology       Date:  2015-10       Impact factor: 4.736

2.  Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation.

Authors:  R L Hull; K Kodama; K M Utzschneider; D B Carr; R L Prigeon; S E Kahn
Journal:  Diabetologia       Date:  2005-06-04       Impact factor: 10.122

3.  Glucose- and time-dependence of islet amyloid formation in vitro.

Authors:  Sakeneh Zraika; Rebecca L Hull; Jayalakshmi Udayasankar; Kristina M Utzschneider; Jenny Tong; Fernando Gerchman; Steven E Kahn
Journal:  Biochem Biophys Res Commun       Date:  2007-01-02       Impact factor: 3.575

Review 4.  The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality.

Authors:  S E Kahn; S Zraika; K M Utzschneider; R L Hull
Journal:  Diabetologia       Date:  2009-03-27       Impact factor: 10.122

5.  Function and survival of intrasplenic islet autografts in dogs.

Authors:  M P van der Burg; O R Guicherit; J B Jansen; M Frölich; C B Lamers; H H Lemkes; J A Bruijn; H G Gooszen
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 6.  Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes.

Authors:  Gordon C Weir; Jason Gaglia; Susan Bonner-Weir
Journal:  Lancet Diabetes Endocrinol       Date:  2020-01-29       Impact factor: 32.069

7.  Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes.

Authors:  Deborah A Elder; Jessica G Woo; David A D'Alessio
Journal:  Pediatr Diabetes       Date:  2010-08       Impact factor: 4.866

8.  Beta-cell hypersensitivity for glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized rats.

Authors:  J L Leahy; L M Bumbalo; C Chen
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

9.  Effect of nifedipine on glucose potentiation of the acute insulin response to arginine in non-insulin-dependent diabetics.

Authors:  M Krempf; S Ranganatan; P Ritz; J M Garnier; B Charbonnel
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

Authors:  Serenella Salinari; Alessandro Bertuzzi; Simone Asnaghi; Caterina Guidone; Melania Manco; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2008-11-25       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.